Ophthalmic Goods Merchant Wholesalers (U.S., NAICS 42346)

1. Overview

NAICS 42346 is the slice of the eyewear supply chain that sits between the factory and the eye doctor: firms that buy eyeglass lenses, frames, sunglasses, contact lenses, and optometric equipment in bulk and resell them to optometrists, opticians, and retailers. (NAICS is the North American Industry Classification System, the federal code the U.S. uses to group businesses.) A "merchant wholesaler" is a distributor that takes legal title to goods, holds inventory, and earns the spread between what it pays a manufacturer and what it charges a professional buyer — plus fees for lab work, fast fulfillment, prescription handling, and software layered on top.[5]

The demand underneath is unusually broad for a consumer-health category: The Vision Council estimates about 250 million U.S. adults, or 94%, regularly used some form of eyewear in 2025 — prescription glasses, readers, or sunglasses.[8] Distribution is the toll booth in the middle of that flow, and the investment question at this level is how much of the toll the independent middleman gets to keep.

This page is a rollup for a general investing audience — relevant to both public-market and private investors. It summarizes the level and points you to the detailed leaf primer for the specifics.

2. What's inside — and why this level equals its one child

A NAICS "industry" at the 5-digit level can contain several 6-digit national industries. NAICS 42346 contains exactly one: 423460, Ophthalmic Goods Merchant Wholesalers. There is no second child to blend in and nothing gets left out — so 42346 and 423460 are, in practice, the same industry under two code lengths. The 5-digit code is the international (North American) rollup; the 6-digit code is the U.S. national detail, and here they line up one-to-one.

Because of that, this page is deliberately short. For the full treatment — structure, named companies, how margins are made, demand drivers, regulation, consolidation, and risks — read the child primer 423460. Everything below is a summary.

3. Size (this level's rollup figures)

Ground-truth federal statistics for NAICS 42346. Since the level has a single child, these are identical to 423460's numbers:[1][2]

With 859 firms across 999 establishments, most firms run a single location. Average pay works out near $77,000 per employee and average revenue near $15 million per firm — typical of a distribution business (high sales per head, modest headcount, a few large players lifting the averages).[1][2]

Shape of the industry: a barbell, not a pyramid. The four largest firms take about 37% of revenue, the top eight about 51%, the top 20 about 70%, and the top 50 about 82%.[2] Yet the Herfindahl-Hirschman Index (HHI, the standard concentration gauge, where under 1,500 counts as "unconcentrated") is just 457.5 — technically fragmented.[2] Both readings are true at once: no single counted wholesaler dominates, but a handful of platforms set the tone above a long tail of small independents and family labs.

What the spread looks like. A separate Census gross-margin profile for merchant wholesalers in this industry (excluding manufacturers' sales branches and offices) reports $12.0 billion of own-account sales against $7.0 billion cost of goods sold, with $1.6 billion of year-end inventory — a 42% gross margin, and Census-defined "gross profit" after operating expenses of $2.2 billion, about 18% of sales.[3] Those are survey constructs that sit ahead of interest, taxes, and some non-operating items, not GAAP net income, but they are the cleanest public read on how much of the toll this level actually keeps.

Undercount caveat — read this. These federal wholesale figures materially understate the real economics of ophthalmic distribution. The dominant flows of lenses, frames, and contact lenses move through vertically integrated giants — EssilorLuxottica, Alcon, CooperVision, Bausch + Lomb, Johnson & Johnson Vision — whose distribution activity is booked under manufacturing (NAICS 339115), not merchant wholesaling. Private trackers that draw the boundary more broadly put "glasses and contacts wholesaling" around $16.5 billion in 2025; the total U.S. eyewear market across all channels was about $40.8 billion, and The Vision Council's broader "optical market" definition, which includes eye exams, reached $69.5 billion in 2025.[6][7][8] Those last two are end-market measures, not wholesale revenue — but they frame how small the $12.7 billion counted slice is relative to the demand chain it feeds.

4. Investable universe (where value concentrates)

Since 42346 is a single child, all of the level's value sits in the same place 423460 describes. In short:

• There is no U.S.-listed pure-play ophthalmic wholesaler. Public-market exposure runs through vertically integrated manufacturer-distributors — most of them foreign-domiciled and accessed via ADRs (American Depositary Receipts, the U.S.-traded stand-ins for foreign shares). The broadest of them earns roughly 47% of group revenue from its wholesale ("Professional Solutions") segment, so the listed proxies are genuinely half-distribution businesses rather than pure manufacturers.[10]
• The firms actually at the center of this industry are private, mostly owned by private-equity firms — led by the largest independent contact-lens distributor.
• The boundary is blurry by design. Optical laboratories buy lens blanks and then surface, coat, and edge to a patient's prescription — work that can sit inside a retailer, a manufacturer, or a wholesaler, so company accounts rarely map cleanly onto this code.

Names, tickers, and scale are in section 4 of the 423460 primer.

5. How the money works

Owners earn a distributor's living: gross margin (buy in bulk, sell at a markup) minus warehousing, logistics, sales force, and credit costs — then stack higher-margin services on top (lab work, prescription verification, financing, practice software, data). Census data put the industry-wide gross margin at 42% with operating expenses near 24% of sales, leaving the rest for interest, taxes, and profit.[3] Recurring consumable demand (contact lenses reorder; prescriptions renew) makes retention compound, and high volume earns manufacturer rebates that separate profitable distributors from unprofitable ones. The structural threat: when a manufacturer sells direct to the practice or owns the retailer — and exclusive supply agreements with large retail chains show how far that reach extends — the middleman's spread disappears. Full detail in section 5 of 423460.

6. Demand drivers

Non-discretionary at the core, discretionary on top: an aging population and rising myopia (nearsightedness) pull more people into corrective lenses; the shift to daily-disposable contacts multiplies unit volume; screen use drives specialty and blue-light lenses; myopia management for children is a growing higher-value segment; and vision insurance steers purchase frequency, with benefit resets making the first half of the year seasonally stronger. Frames and sunglasses add a fashion-driven, more cyclical premium layer — and in 2025 that layer did the work: The Vision Council found the U.S. optical market grew in dollars even as unit volume and eye exams declined, meaning price and mix, not traffic, carried growth.[8] Channel shift is real but partial: a late-2024 survey found 86% of recent eyeglass purchases still happened in person, while 35% of contact-lens purchases moved online — fitting complexity protects the practice channel for spectacles, standardized replenishment does not.[9] See section 6 of 423460.

7. Regulation

Contact lenses and lens-care solutions are FDA-regulated medical devices, not general merchandise. (FDA is the U.S. Food and Drug Administration.) So, less obviously, are spectacle lenses, frames, and sunglasses: generally exempt from premarket review, but manufacturers and initial importers must register and list, quality-system rules apply, and lenses must meet the impact-resistance requirement in 21 CFR 801.410 — noncompliant imports can be detained.[13] The FTC Contact Lens Rule (Federal Trade Commission; 16 CFR Part 315), implementing the Fairness to Contact Lens Consumers Act, forces prescribers to release prescriptions and lets patients buy from any seller — which is why mail-order and online contact-lens distribution exists at scale.[11] The FTC's updated Eyeglass Rule (2024) extends comparable automatic prescription release to spectacles and adds recordkeeping duties for financially interested prescribers, which helps independent and online sellers while raising compliance burden at integrated practices.[12] State licensing governs who may prescribe and dispense, and antitrust scrutiny follows the industry's vertical mergers. Full detail in section 7 of 423460.

8. Consolidation

The defining feature is vertical integration by a few giants (EssilorLuxottica spans lens and frame manufacturing, wholesale, retail chains, and optometrist networks) plus active roll-ups of the independent distribution tier by private equity. The consolidation is ongoing, not historical: VSP Vision completed its acquisition of Marcolin in December 2025, further concentrating frame distribution under an owner that is also a major vision insurer.[14] Independent distributors defend a "neutral supplier" position to eye doctors who would rather not buy from a manufacturer that also owns competing retail. See section 8 of 423460.

9. Risks

Margin compression as manufacturers sell direct; the vertical-integration squeeze from integrated giants; supplier concentration (a few manufacturers control lens and contact supply); e-commerce disintermediation around the professional channel; regulatory and vision-plan-reimbursement shifts; import/tariff exposure on frames, most of which are sourced abroad; cyclicality in the premium layer; optometrist shortages and wage pressure that cap exam capacity and therefore prescription volume upstream of every distributor; and technology disruption from smart eyewear whose value may accrue to large manufacturers rather than neutral distributors. Full list in section 9 of 423460.

10. How to invest & outlook

Because no pure-play wholesaler is listed, public-market exposure runs through integrated manufacturer-distributors (EssilorLuxottica is the broadest single proxy) and contact-lens / eye-care makers, most accessed via ADRs; the retail end of the same demand chain offers additional listed names. Private-market exposure means private-equity fund positions, secondaries, or acquiring/operating a regional distributor or lab — roll-ups of independent labs and distributors remain an active thesis, with the usual diligence traps being customer and supplier concentration, rebates that flatter reported margin, obsolete frame inventory, and understated lab capital expenditure. The demand backdrop is favorable and durable (aging population, myopia epidemic, mix shift to daily disposables, premiumization), with the broader U.S. eyewear market projected to grow around 4.6% annually into the early 2030s.[7] The counterweight is channel economics, as vertical integration and direct-to-consumer selling keep pressure on the independent distributor's spread. Tickers, specific routes, and the full outlook are in section 10 of the 423460 primer.

---

Sources

1. U.S. Census Bureau, County Business Patterns, 2023 (NAICS 423460) — establishments, employment, annual and Q1 payroll. https://www.census.gov/programs-surveys/cbp.html
2. U.S. Census Bureau, 2022 Economic Census — Concentration/Selected Statistics (NAICS 423460) — receipts, firms, CR4/CR8/CR20/CR50, HHI. https://www.census.gov/programs-surveys/economic-census.html
3. U.S. Census Bureau, 2022 Economic Census — Gross Margin Profile (NAICS 423460, EC2242GRMARGPROF). https://data.census.gov/table/ECNGRMARGPROF2022.EC2242GRMARGPROF
4. U.S. Small Business Administration, Table of Small Business Size Standards (2023). https://www.sba.gov/document/support-table-size-standards
5. NAICS Association / U.S. Census Bureau, NAICS 423460 — Ophthalmic Goods Merchant Wholesalers (definition), 2022. https://www.naics.com/naics-code-description/?code=423460
6. IBISWorld, Glasses & Contacts Wholesaling in the US, 2025/2026. https://www.ibisworld.com/united-states/industry/glasses-contacts-wholesaling/931/
7. MarketDataForecast, U.S. Eyewear Market Size, Share & Growth, 2025. https://www.marketdataforecast.com/market-reports/united-states-eyewear-market
8. The Vision Council, Market inSights 2025. https://thevisioncouncil.org/blog/us-optical-industry-reaches-695-billion-despite-declines-product-volume-and-eye-exams
9. The Vision Council, Consumer inSights Q4 2024. https://thevisioncouncil.org/product/consumer-insights-q4-2024-report
10. Swissquote, Your eyes only: 8 companies to watch (EssilorLuxottica segment mix), 2024. https://www.swissquote.com/en-lu/private/inspire/swissquote-magazine/your-eyes-only/8-companies-watch
11. Federal Trade Commission, The Contact Lens Rule: A Guide for Prescribers and Sellers. https://www.ftc.gov/business-guidance/resources/contact-lens-rule-guide-prescribers-sellers
12. Federal Trade Commission, FTC Announces Final Eyeglass Rule, 2024. https://www.ftc.gov/news-events/news/press-releases/2024/06/ftc-announces-final-eyeglass-rule-implementing-updates-promote-competition-expand-consumer-choice
13. U.S. Food & Drug Administration, Sunglasses, Spectacle Frames, Spectacle Lens, and Magnifying Spectacles. https://www.fda.gov/medical-devices/guidance-documents-medical-devices-and-radiation-emitting-products/sunglasses-spectacle-frames-spectacle-lens-and-magnifying-spectacles
14. VSP Vision / Marcolin, VSP Vision Completes Marcolin Acquisition (Press Release, December 2025). https://www.marcolin.com/wp-content/uploads/2025/12/VSP-Vision-completes-Marcolin-Acquisition_Press-Release-December_ENG.pdf
15. Child primer 423460 (this repository), Ophthalmic Goods Merchant Wholesalers (U.S., NAICS 423460) — full company detail, economics, regulation, consolidation, and outlook. See Sources 1–41 therein.